Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-08T22:08:02.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study record page now returns a 403 Forbidden error, replacing the detailed study information with an access-denied message. This blocks viewing the record and its related materials on the page.
    Difference
    18%
    Check dated 2026-09-24T21:36:16.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.7.0 appears on the page, replacing Revision: v3.6.6. This reflects an internal update to the page's revision/versioning, not a change to the study content presented to users.
    Difference
    0.1%
    Check dated 2026-09-17T22:04:51.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.6.6 has been added and the prior Revision: v3.6.5 has been removed. This reflects a minor system or documentation update for the page rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-27T19:44:36.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Removed the Notice header and the text about intermittent NCBI service delays from the page, eliminating the site-wide outage message and leaving the study information intact.
    Difference
    0.1%
    Check dated 2026-08-20T20:06:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A site-wide notice about intermittent delays was added. The revision version was updated from v3.6.4 to v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-13T18:38:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.